A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection - Contacts and Locations

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

This study has been completed.

Study NCT00000984. Last updated on June 23, 2005. Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000984

Locations


United States, California
	Stanford Univ School of Medicine / Pediatrics
	Stanford, California, United States, 943054149
	Northern California Pediatric AIDS Treatment Ctr / UCSF
	San Francisco, California, United States, 94143

United States, Illinois
	Chicago Children's Memorial Hosp
	Chicago, Illinois, United States, 606143394
	Children's Memorial Med Ctr
	Chicago, Illinois, United States, 60614

United States, New Jersey
	Children's Hosp of New Jersey / UMDNJ - New Jersey Med Schl
	Newark, New Jersey, United States, 071072198

United States, North Carolina
	Duke Univ Med Ctr
	Durham, North Carolina, United States, 277103499

Sponsors and Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Genentech

Investigators


Study Chair:	P Weintrub